Phase 2 trial of ozuriftamab vedotin (BA3021), a conditionally binding ROR2-ADC, in patients with heavily pretreated squamous cell carcinoma of the head and neck. Mechanisms of resistance to anti-PD1 ...
A research paper by scientists from Beihang University proposed a machine learning (ML)-driven cerebral blood flow (CBF) prediction model, featuring multimodal imaging data integration and an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback